283 related articles for article (PubMed ID: 27916625)
1. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
2. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
4. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG
Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900
[TBL] [Abstract][Full Text] [Related]
5. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
Sasano H; Suzuki T; Moriya T
Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
[TBL] [Abstract][Full Text] [Related]
9. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
10. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.
Stojadinovic A; Ghossein RA; Hoos A; Nissan A; Marshall D; Dudas M; Cordon-Cardo C; Jaques DP; Brennan MF
J Clin Oncol; 2002 Feb; 20(4):941-50. PubMed ID: 11844815
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
Volante M; Bollito E; Sperone P; Tavaglione V; Daffara F; Porpiglia F; Terzolo M; Berruti A; Papotti M
Histopathology; 2009 Nov; 55(5):535-43. PubMed ID: 19912359
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
Mete O; Gucer H; Kefeli M; Asa SL
Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
[TBL] [Abstract][Full Text] [Related]
15. Oncocytic Adreno Cortical Tumors: Pathological Features of 16 Cases and Review of the Literature.
Ertan Y; Argon A; Özdemir M; Yürekli BPS; Dökümcü Z; Makay Ö
J Environ Pathol Toxicol Oncol; 2017; 36(3):237-244. PubMed ID: 29283337
[TBL] [Abstract][Full Text] [Related]
16. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
[TBL] [Abstract][Full Text] [Related]
17. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
18. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
Lau SK; Weiss LM
Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
